# SITE Centers Corp.: financial statements, quarterly

SITC · NYSE · CIK 894315 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sitc.md) · [Financials](/companies/sitc/financials.md) · [Filings](/companies/sitc/filings.md) · [Insiders](/companies/sitc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sitc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [145](/filings/0000950170-24-118598.md) | [(415) d](/filings/0001193125-26-076905.md) | [94.1](/filings/0000950170-25-065759.md) | [87.5](/filings/0000950170-25-103102.md) | [61.0](/filings/0001193125-25-267060.md) | [(236) d](/filings/0001193125-26-076905.md) | [42.6](/filings/0001193125-26-211986.md) | [33.5](/filings/0001193125-26-330598.md) | [27.1](/filings/0001193125-25-267060.md) | [(84.9) d](/filings/0001193125-26-076905.md) | [13.0](/filings/0001193125-26-211986.md) | [10.7](/filings/0001193125-26-330598.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [21.1](/filings/0000950170-23-057442.md) | [20.0 d](/filings/0000950170-24-019352.md) | [18.9](/filings/0000950170-24-051246.md) | [18.4](/filings/0000950170-24-088552.md) | [16.7](/filings/0001193125-25-267060.md) | [5.8 d](/filings/0001193125-26-076905.md) | [5.5](/filings/0001193125-26-211986.md) | [5.3](/filings/0001193125-26-330598.md) | [4.0](/filings/0001193125-25-267060.md) | [0.5 d](/filings/0001193125-26-076905.md) | [0.0](/filings/0001193125-26-211986.md) | [0.0](/filings/0001193125-26-330598.md) |
| Income tax | $m | [0.2](/filings/0000950170-24-118598.md) | [1.2 d](/filings/0001193125-26-076905.md) | [0.3](/filings/0000950170-25-065759.md) | [0.3](/filings/0000950170-25-103102.md) | [0.2](/filings/0001193125-25-267060.md) | [0.0 d](/filings/0001193125-26-076905.md) | [0.1](/filings/0001193125-26-211986.md) | [0.2](/filings/0001193125-26-330598.md) | [0.2](/filings/0001193125-25-267060.md) | [(0.7) d](/filings/0001193125-26-076905.md) | [(0.2)](/filings/0001193125-26-211986.md) | [0.1](/filings/0001193125-26-330598.md) |
| Net income | $m | [48.6](/filings/0000950170-24-118598.md) | [196 d](/filings/0001193125-26-076905.md) | [(23.6)](/filings/0000950170-24-051246.md) | [238](/filings/0000950170-24-088552.md) | [323](/filings/0000950170-24-118598.md) | [(5.8) d](/filings/0001193125-26-076905.md) | [3.1](/filings/0001193125-26-211986.md) | [46.5](/filings/0001193125-26-330598.md) | [(6.2)](/filings/0001193125-25-267060.md) | [134 d](/filings/0001193125-26-076905.md) | [0.9](/filings/0001193125-26-211986.md) | [(1.3)](/filings/0001193125-26-330598.md) |
| Diluted EPS | $ per share | [0.87](/filings/0000950170-24-118598.md) | not reported | [(0.51)](/filings/0000950170-25-065759.md) | [4.45](/filings/0000950170-25-103102.md) | [6.07](/filings/0001193125-25-267060.md) | not reported | [0.06](/filings/0001193125-26-211986.md) | [0.88](/filings/0001193125-26-330598.md) | [(0.13)](/filings/0001193125-25-267060.md) | not reported | [0.02](/filings/0001193125-26-211986.md) | [(0.03)](/filings/0001193125-26-330598.md) |
| Basic EPS | $ per share | [0.87](/filings/0000950170-24-118598.md) | not reported | [(0.51)](/filings/0000950170-25-065759.md) | [4.49](/filings/0000950170-25-103102.md) | [6.09](/filings/0001193125-25-267060.md) | not reported | [0.06](/filings/0001193125-26-211986.md) | [0.88](/filings/0001193125-26-330598.md) | [(0.13)](/filings/0001193125-25-267060.md) | not reported | [0.02](/filings/0001193125-26-211986.md) | [(0.03)](/filings/0001193125-26-330598.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.6](/filings/0000950170-23-057442.md) | [551](/filings/0000950170-25-029989.md) | [551](/filings/0000950170-24-051246.md) | [1,181](/filings/0000950170-24-088552.md) | [1,063](/filings/0000950170-24-118598.md) | [54.6](/filings/0001193125-26-076905.md) | [58.2](/filings/0000950170-25-065759.md) | [154](/filings/0000950170-25-103102.md) | [128](/filings/0001193125-25-267060.md) | [119](/filings/0001193125-26-330598.md) | [193](/filings/0001193125-26-211986.md) | [239](/filings/0001193125-26-330598.md) |
| Total assets | $m | [4,025](/filings/0000950170-23-057442.md) | [4,061](/filings/0000950170-25-029989.md) | [3,893](/filings/0000950170-24-051246.md) | [4,046](/filings/0000950170-24-088552.md) | [3,127](/filings/0000950170-24-118598.md) | [934](/filings/0001193125-26-076905.md) | [930](/filings/0000950170-25-065759.md) | [959](/filings/0000950170-25-103102.md) | [654](/filings/0001193125-25-267060.md) | [419](/filings/0001193125-26-330598.md) | [402](/filings/0001193125-26-211986.md) | [365](/filings/0001193125-26-330598.md) |
| Total liabilities | $m | [1,978](/filings/0000950170-23-057442.md) | [1,886](/filings/0000950170-25-029989.md) | [1,769](/filings/0000950170-24-051246.md) | [1,711](/filings/0000950170-24-088552.md) | [475](/filings/0000950170-24-118598.md) | [417](/filings/0001193125-26-076905.md) | [410](/filings/0000950170-25-065759.md) | [472](/filings/0000950170-25-103102.md) | [346](/filings/0001193125-25-267060.md) | [84.0](/filings/0001193125-26-330598.md) | [66.0](/filings/0001193125-26-211986.md) | [83.0](/filings/0001193125-26-330598.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,047](/filings/0000950170-23-057442.md) | [2,176](/filings/0000950170-25-029989.md) | [2,124](/filings/0000950170-24-051246.md) | [2,334](/filings/0000950170-24-088552.md) | [2,652](/filings/0000950170-24-118598.md) | [517](/filings/0001193125-26-076905.md) | [520](/filings/0000950170-25-065759.md) | [487](/filings/0000950170-25-103102.md) | [308](/filings/0001193125-25-267060.md) | [335](/filings/0001193125-26-330598.md) | [336](/filings/0001193125-26-211986.md) | [282](/filings/0001193125-26-330598.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [65.3 d](/filings/0000950170-24-118598.md) | [46.5 d](/filings/0001193125-26-076905.md) | [40.0](/filings/0000950170-25-065759.md) | [66.5 d](/filings/0000950170-25-103102.md) | [36.8 d](/filings/0001193125-25-267060.md) | [(31.2) d](/filings/0001193125-26-076905.md) | [5.7](/filings/0001193125-26-211986.md) | [17.2 d](/filings/0001193125-26-330598.md) | [5.2 d](/filings/0001193125-25-267060.md) | [(8.5) d](/filings/0001193125-26-076905.md) | [(4.3)](/filings/0001193125-26-211986.md) | [(10.1) d](/filings/0001193125-26-330598.md) |
| Dividends paid | $m | [30.0 d](/filings/0000950170-24-118598.md) | [30.1 d](/filings/0001193125-26-076905.md) | [63.7](/filings/0000950170-25-065759.md) | [30.1 d](/filings/0000950170-25-103102.md) | [30.1 d](/filings/0001193125-25-267060.md) | [4.1 d](/filings/0001193125-26-076905.md) | [0.0](/filings/0000950170-25-065759.md) | [0.0 d](/filings/0000950170-25-103102.md) | [250 d](/filings/0001193125-25-267060.md) | [105 d](/filings/0001193125-26-076905.md) | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-118598.md) | [0.0 d](/filings/0001193125-26-076905.md) | [0.0](/filings/0000950170-24-051246.md) | [0.0 d](/filings/0000950170-24-088552.md) | [0.0 d](/filings/0000950170-24-118598.md) | [0.0 d](/filings/0001193125-26-076905.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [214](/filings/0000950170-23-057442.md) | [210](/filings/0000950170-24-051246.md) | [209](/filings/0000950170-24-088552.md) | [52.4](/filings/0000950170-24-118598.md) | [52.4](/filings/0000950170-25-065759.md) | [52.8](/filings/0000950170-25-103102.md) | [52.6](/filings/0001193125-25-267060.md) | [52.4](/filings/0001193125-26-211986.md) | [52.4](/filings/0001193125-26-330598.md) | [52.4](/filings/0001193125-25-267060.md) | [52.5](/filings/0001193125-26-211986.md) | [52.5](/filings/0001193125-26-330598.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,475,339 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0001193125-26-330598.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.